...
首页> 外文期刊>American Journal of PharmTech Research >Liposomes: Benchmark in the Era of Drug Carriers for Semisolid Based Topical Delivery System
【24h】

Liposomes: Benchmark in the Era of Drug Carriers for Semisolid Based Topical Delivery System

机译:脂质体:基于半固体的局部递送系统在药物载体时代的基准

获取原文
           

摘要

ABSTRACT A liposome is a microscopic vesicle consisting of an aqueous core enclosed in one or more phospholipid layers, used to convey vaccines, drugs, enzymes, or other substances to target cells or organs. Liposomes are bilayered structures made of amphipathic (both hydrophobic and hydrophilic) phospholipids/cholesterol that spontaneously form closed structures when hydrated in aqueous solutions. Liposomes are acceptable and superior carriers having ability to encapsulate hydrophilic and lipophilic drugs and protect them from degradation. Topical liposomes have similarity to biological membranes they can store water-soluble and lipophilic substances in their different phases. Moreover, they are similar to the epidermis with respect to their lipid composition, which enables them to penetrate the epidermal barrier to a greater extent compared to other dosage forms. According to studies performed so far liposomes are biodegradable and non-toxic. The really new aspect with liposomes is that they are thought to act not only as drug transporters but also drug localizers. Thus vehicles can transport drugs to the wanted site of action within the skin by preventing systemic absorption and consecutively unwanted effects. The liposomal semisolid formulations could perform therapeutically better effects than the conventional formulations, as prolonged and controlled release topical dosage forms, which may lead to improved efficiency and better patient compliance. Such review giving an emphasis on topically applied liposomal formulations which encompasses methods of preparation, evaluation, mechanisms for enhancement in drug delivery through the skin and regulatory requirements necessitates as topical dosage form. Keywords: Liposomes, Carriers, Topical, Evaluation
机译:摘要脂质体是一种微观囊泡,由包裹在一个或多个磷脂层中的水核心组成,用于将疫苗,药物,酶或其他物质输送到靶细胞或器官。脂质体是由两亲性(疏水性和亲水性)磷脂/胆固醇制成的双层结构,当在水溶液中水合时会自发形成封闭结构。脂质体是可接受的并且具有优良的载体,其具有包封亲水性和亲脂性药物并保护其免于降解的能力。局部脂质体与生物膜具有相似性,它们可以在其不同阶段存储水溶性和亲脂性物质。此外,它们的脂质组成与表皮相似,与其他剂型相比,它们能够更大程度地穿透表皮屏障。根据迄今为止进行的研究,脂质体是可生物降解的并且是无毒的。脂质体的真正新方面是,它们不仅被认为可以充当药物转运蛋白,而且可以充当药物定位剂。因此,车辆可以通过防止系统吸收和连续产生的不良作用,将药物运输到皮肤内所需的作用部位。脂质体半固体制剂与常规制剂相比,具有延长的和受控释放的局部剂型,可以实现比常规制剂更好的治疗效果,从而可以提高效率并改善患者依从性。这种综述着重于局部施用的脂质体制剂,其包括制备,评价,通过皮肤增强药物递送的机制和调节要求作为局部剂型所必需。关键字:脂质体,载体,局部,评价

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号